Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

Overview
Date Founded

1987

Headquarters

11500 South Eastern Avenue, Suite 240, Henderson, NV, 89052, USA

Type of Company

Public

Employees (Worldwide)

176

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

Contact Data
Trying to get in touch with decision makers at Spectrum Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Chief Operating Officer

Senior Vice President, Chief Scientific Officer & Head of Research & Development Operations

Executive Vice President, Chief Legal Officer & Corporate Secretary

Executive Vice President & Chief Medical Officer

Vice President-Corporate & Business Development

Senior Director, Marketing

Senior Director

Senior Director

Board of Directors

Principal at Harrison Consulting Group, Inc.

Chief Financial Officer at Fore Biotherapeutics, Inc.

Partner at IPF Management I SARL

Director, President & Chief Executive Officer at Spectrum Pharmaceuticals, Inc.

Executive Chairman at JenaValve Technology, Inc.

Medical Director at The Mount Sinai Hospital

Former Chief Executive Officer, Chief Commercial Officer & Director at VIVUS, Inc.

Paths to Spectrum Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Spectrum Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

Armistice Capital is a global, long/short, value-oriented and event-driven hedge fund firm which focuses primarily on the health care and consumer sectors. They invest predominantly in equities and can be opportunistic across the capital structure. The firm seeks to maximize the opportunity set of investment candidates allowing for the selection of unique, concentrated bets to generate uncorrelated returns. They maintain significant position and portfolio level hedges in an effort to mitigate basis and market risks. Armistice Capital employs a bottom-up analysis, assessing all components of the company’s capital structure and aims to take larger positions where the greatest potential risk adjusted return exists. Armistice Capital’s Domestic Fund and the Offshore Fund, through their investments in the Master Fund, seek to achieve long-term capital appreciation by employing an opportunistic global long/short strategy for investing in distressed debt, value equities and event equities. In all of its investing activities, the Funds will seek to emphasize capital preservation and will seek to mitigate risk through various hedging strategies at both the position and portfolio levels.

Details Hidden

Alethea Capital Management LLC is a private company headquartered in Rancho Santa Fe, CA, with domestic subsidiaries. The firm provides investment advice. It was founded in 2011 by Tony Hsu, he has been the CEO since then.

Details Hidden

CM Management invests primarily in undervalued, misunderstood, mispriced and undiscovered small-cap and micro-cap stocks listed on US stock exchanges.

Recent Transactions
Details Hidden

Spectrum Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Spectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Details Hidden

Spectrum Pharmaceuticals, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Investment Advisor

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Legal Advisor

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Underwriter

Advised onSpectrum Pharmaceuticals, Inc. issued USD Common Stock

Corporate Officer

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Legal Advisor

Advised onSpectrum Pharmaceuticals, Inc. purchases Talon Therapeutics, Inc. from Warburg Pincus LLC

Associate

Advised onSpectrum Pharmaceuticals, Inc. purchases Allos Therapeutics, Inc.

Advisors & Consultants
Legal Advisor

Shareholder at Stradling, Yocca Carlson & Rauth PC

Legal Advisor

Partner at Latham & Watkins LLP

Legal Advisor

Adjunct Professor at University of Southern California Gould School of Law

Clients

Nippon Kayaku Co., Ltd. engages in the manufacture and sale of chemicals. It operates through the following segments: Functional Chemicals, Pharmaceuticals, Safety Systems, and Others. The Functional Chemicals segment provides products in the environment and energy conservation fields based on dye and resin technology. The Pharmaceuticals segment centers on anti-cancer drugs and cancer related fields. The Safety Systems segment handles the improvement of automobile safety through applied explosive technologies that includes airbag inflators and gas generators. The Others segment deals with agrochemicals and real estate leasing. The company was founded by Jotaro Yamamoto, Naokichi Kaneko, and Soubei Mogi on June 5, 1916 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of 2020
Market Capitalization
$522M
Total Enterprise Value
$247M
Earnings Per Share
$-1.29
Revenue
$0
TEVNet Income
-1.53x
Debt TEV
0.01x
Total Equity
$134M
Total Debt
$2.43M
Net Profit
$-161M
EBITDA
$-168M
Three Year Compounded Annual Growth Rate Of Revenue
-100%
Non-Profit Donations & Grants
$25K - $50K
2018
$50K - $100K
2017
$5,000 - $10K
2017
Suppliers
Arbutus Biopharma Corp. Medical Support Services | Burnaby, Canada

Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals | Hwaseong, South Korea

Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for high blood pressure, hyperlipidemia, reflux esophagitis, and cerebrovascular disease. The company was founded by Lim Sung-Gi on June 15, 1973 and is headquartered in Hwaseong, South Korea.

ImmunGene, Inc. Pharmaceuticals | Camarillo, CA

ImmunGene, Inc. is an American private company located in Camarillo, CA. The firm provides drug discovery and development services.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $82.6 billion during calendar year 2020. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.

AstraZeneca Plc Pharmaceuticals - Cambridge, United Kingdom

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Spectrum Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Spectrum Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Spectrum Pharmaceuticals, Inc..